Alcon Stock

Alcon Gross Profit

The Gross Profit of Alcon (ALC.SW) as of Aug 12, 2026 is 4.90 B USD. In the previous year, Gross Profit was 4.49 B USD — a change of 9.19% (higher).

Gross Profit

4.90 BUSD

YoY

9.19%

Last updated:

Gross Profit of Alcon is 2026 4.90 B USD. Gross Profit of Alcon was 2025 4.49 B USD. It decreases by 9.19% higher compared to the previous year.

The Alcon Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2023
55.49 base
Jan 1, 2024
55.61 base
Jan 1, 2025
55.24 base
Jan 1, 2026 (e)
44.65 base
Jan 1, 2027 (e)
42.07 base
Jan 1, 2028 (e)
39.68 base
Jan 1, 2029 (e)
37.51 base
Jan 1, 2030 (e)
35.06 base
YEARGROSS MARGIN (%)
2030 est 35.06
2029 est 37.51
2028 est 39.68
2027 est 42.07
2026 est 44.65
2025 55.24
2024 55.61
2023 55.49
2022 54.47
2021 56.11
2020 43.03
2019 48.77
2018 43.87
2017 47.17
2016 47.16
2015 47.95
Access this data via the Eulerpool API

Alcon Revenue

Alcon Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
7.70 B USD
830.98 M USD
792.73 M USD
Jan 1, 2024
8.07 B USD
1.15 B USD
828.54 M USD
Jan 1, 2025
8.87 B USD
1.16 B USD
835.56 M USD
Jan 1, 2026 (e)
10.97 B USD
1.14 B USD
1.70 B USD
Jan 1, 2027 (e)
11.64 B USD
1.21 B USD
1.94 B USD
Jan 1, 2028 (e)
12.35 B USD
1.28 B USD
2.19 B USD
Jan 1, 2029 (e)
13.06 B USD
1.35 B USD
2.54 B USD
Jan 1, 2030 (e)
13.97 B USD
1.45 B USD
2.88 B USD

Alcon Margins

Alcon stock margins

The Alcon margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alcon. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alcon.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
55.49 %
10.80 %
10.30 %
Jan 1, 2024
55.61 %
14.26 %
10.27 %
Jan 1, 2025
55.24 %
13.08 %
9.42 %
Jan 1, 2026 (e)
55.24 %
10.36 %
15.47 %
Jan 1, 2027 (e)
55.24 %
10.36 %
16.68 %
Jan 1, 2028 (e)
55.24 %
10.36 %
17.78 %
Jan 1, 2029 (e)
55.24 %
10.36 %
19.46 %
Jan 1, 2030 (e)
55.24 %
10.36 %
20.60 %

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcon stock

Gross Profit of Alcon is 4.90 B USD in 2026.

Gross Profit of Alcon changed from 4.49 B USD to 4.90 B USD, representing a 9.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Alcon since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Alcon historically and in real time.

Access this data via the Eulerpool API

Income Statement — Alcon

All Key Metrics — Alcon